Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Pediatric Acute Liver Failure: Definitive Diagnosis Key for Targeted Treatment
-
- 8 Recent Developments in C. difficile Infection
- Identifying, Managing Comorbidity of Celiac, IBD Ciaran Kelly, MD; Toufic Kabbani, MD
- First Patient Treated in Phase 3 Trial for HCC Medication Pexa-Vec
- FDA Grants Orphan Drug Designation to BTT1023 for PSC
- SYN-010 for IBS-C to Enter Phase 3 Development Following FDA Meeting
- UPSTART: Phase 2 Trial of ATPase Modulator Initiated in UC
- Experts, More Research Needed for Best Treatment of PALF
- Advances in Ulcerative Colitis Management: Targeting Inflammation to Achieve Remission Across the Disease Spectrum
-
- Certain Probiotics Improve H. pylori Eradication Rates, Prevent Adverse Events
- Gluten-free Celiac Patients Frequently Experience Symptomatic Gluten Exposure
- New Study Supports Hygiene Hypothesis in IBD, Shows Ethnicity Influences Risk
- Researchers Identify Potential Non-invasive Biomarkers for EoE
- Epclusa Shows Manageable Drug Interaction Profile With Antiretrovirals
- AGA Receives NIH Funding for First National FMT Registry
- CMS Confirms Medicare Advantage Coverage of Cologuard Without Cost Sharing
- FDA Issues Boxed Warning for HBV Recurrence From Certain DAAs
-
- Coverage Expands for Cologuard Stool DNA Test for CRC Screening
- NIH Awards $2.39 Million for Research on Amino Acids, IBD
- NIH Grants $1.8 Million for Gut Microbiome Research in Obesity, Metabolic Syndrome